Keywords: Meningococcal C conjugate vaccine; Vaccination coverage; Electronic immunization registries; Seroprevalence studies; Validation studies; Underreporting; Bayesian model;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Meningococcal C conjugate vaccine effectiveness before and during an outbreak of invasive meningococcal disease due to Neisseria meningitidis serogroup C/cc11, Tuscany, Italy
Keywords: Invasive meningococcal disease; Meningococcal C conjugate vaccine; Vaccine effectiveness; Outbreak;
Epidemiology of serogroup C and Y invasive meningococcal disease (IMD) in Ontario, 2000-2013: Vaccine program impact assessment
Keywords: IMD; invasive meningococcal disease; CFR; case fatality ratio; MCCV; meningococcal C conjugate vaccine; MCV4; quadrivalent meningococcal vaccine (serogroup A, C, Y and W); iPHIS; integrated Public Health Information System; PHOL; Public Health Ontario Lab
Single priming dose of meningococcal group C conjugate vaccine (NeisVac-C®) in infants
Keywords: AE; adverse event; CI; confidence interval; GCP; good clinical practice; GMT; geometric mean titer; ICH; International Conference on Harmonization; IU; international unit; MCC; meningococcal C conjugate vaccine; rSBA; serum bactericidal activity (using ra
Natural and vaccine-induced immunity to Neisseria meningitidis serogroup C in asplenic patients with β-thalassemia
Keywords: Meningococcal C conjugate vaccine; β-Thalassemia; Children; Splenectomy;
Cost-Effectiveness Analysis of a Universal Infant Immunization Program with Meningococcal C Conjugate Vaccine in Brazil
Keywords: Brazil; childhood; cost-effectiveness analysis; meningococcal C conjugate vaccine; vaccination program
Meningococcal C conjugate vaccine: The experience in England and Wales
Keywords: Meningococcal serogroup C disease; Meningococcal C conjugate vaccine; Surveillance;
Immunogenicity, safety and tolerability of meningococcal C CRM197 conjugate vaccine administered 3, 5 and 11 months post-natally to pre- and full-term infants
Keywords: Neisseria meningitidis; Meningococcal C conjugate vaccine; Pre-term infants